Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for PTN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 1.776M
December 31, 2025 1.757M
September 30, 2025 0.9733M
June 30, 2025 0.9296M
March 31, 2025 28.56M
December 31, 2024 23.46M
September 30, 2024 19.55M
June 30, 2024 17.93M
March 31, 2024 16.14M
December 31, 2023 14.31M
September 30, 2023 0.2389M
June 30, 2023 0.2331M
March 31, 2023 0.2231M
December 31, 2022 0.2071M
September 30, 2022 9.290M
June 30, 2022 9.271M
March 31, 2022 9.271M
December 31, 2021 9.268M
September 30, 2021 9.252M
June 30, 2021 9.202M
March 31, 2021 9.202M
December 31, 2020 9.201M
September 30, 2020 9.194M
June 30, 2020 9.170M
March 31, 2020 9.170M
Date Value
December 31, 2019 9.167M
September 30, 2019 9.108M
June 30, 2019 9.073M
March 31, 2019 8.122M
December 31, 2018 8.122M
September 30, 2018 8.121M
June 30, 2018 8.022M
March 31, 2018 7.819M
December 31, 2017 7.815M
September 30, 2017 7.376M
June 30, 2017 6.421M
March 31, 2017 5.796M
December 31, 2016 5.337M
September 30, 2016 3.712M
June 30, 2016 0.0549M
March 31, 2016 2.722M
December 31, 2015 2.721M
September 30, 2015 2.721M
June 30, 2015 2.285M
March 31, 2015 1.686M
December 31, 2014 1.662M
September 30, 2014 1.580M
June 30, 2014 1.577M
March 31, 2014 1.570M
December 31, 2013 1.568M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Decoy Therapeutics, Inc. 0.532M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M
Anika Therapeutics, Inc. 13.38M
Savara, Inc. 205.40M